BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 37996237)

  • 21. Professional roles of general practitioners, community pharmacists and specialist providers in collaborative medication deprescribing - a qualitative study.
    Gerlach N; Michiels-Corsten M; Viniol A; Schleef T; Junius-Walker U; Krause O; Donner-Banzhoff N
    BMC Fam Pract; 2020 Sep; 21(1):183. PubMed ID: 32887551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multidisciplinary DEprescribing review for Frail oldER adults in long-term care (DEFERAL): Implementation strategy design using behaviour science tools and stakeholder engagement.
    Heinrich CH; McHugh S; McCarthy S; Curran GM; Donovan MD
    Res Social Adm Pharm; 2023 Aug; 19(8):1202-1213. PubMed ID: 37230873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reducing unplanned hospital admissions from care homes: a systematic review.
    Chambers D; Cantrell A; Preston L; Marincowitz C; Wright L; Conroy S; Lee Gordon A
    Health Soc Care Deliv Res; 2023 Oct; 11(18):1-130. PubMed ID: 37916580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deprescribing as an Opportunity to Facilitate Patient-Centered Care: A Qualitative Study of General Practitioners and Pharmacists in Japan.
    Ie K; Machino R; Albert SM; Tomita S; Kushibuchi M; Hirose M; Matsuda T; Okuse C; Ohira Y
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834238
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenges and opportunities in creating a deprescribing program in the emergency department: A qualitative study.
    Lee S; Bobb Swanson M; Fillman A; Carnahan RM; Seaman AT; Reisinger HS
    J Am Geriatr Soc; 2023 Jan; 71(1):62-76. PubMed ID: 36258309
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nursing home team-care deprescribing study: a stepped-wedge randomised controlled trial protocol.
    Kua CH; Yeo CYY; Char CWT; Tan CWY; Tan PC; Mak VS; Lee SWH; Leong IY
    BMJ Open; 2017 May; 7(5):e015293. PubMed ID: 28490560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Person-centred deprescribing for patients living with frailty: a qualitative interview study and proposal of a collaborative model.
    Peat G; Fylan B; Breen L; Raynor DK; Olaniyan J; Alldred DP
    Int J Pharm Pract; 2023 May; 31(3):282-289. PubMed ID: 37068006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Health care professionals' attitudes towards deprescribing in older patients with limited life expectancy: A systematic review.
    Lundby C; Graabaek T; Ryg J; Søndergaard J; Pottegård A; Nielsen DS
    Br J Clin Pharmacol; 2019 May; 85(5):868-892. PubMed ID: 30630219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Staff experiences with implementing a case conferencing care model in nursing homes: a focus group study.
    Nakrem S; Stensvik GT; Skjong RJ; Ostaszkiewicz J
    BMC Health Serv Res; 2019 Mar; 19(1):191. PubMed ID: 30917815
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health Care Practitioners' Perspectives on Deprescribing Anticholinergic and Sedative Medications in Older Adults.
    Kouladjian L; Gnjidic D; Reeve E; Chen TF; Hilmer SN
    Ann Pharmacother; 2016 Aug; 50(8):625-36. PubMed ID: 27257284
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Delivering the right information to the right person at the right time to facilitate deprescribing in hospital: a mixed methods multisite study to inform decision support design in Australia.
    Baysari MT; Duong M; Zheng WY; Nguyen A; Lo S; Ng B; Ritchie A; Le Couteur D; McLachlan A; Bennett A; Hilmer S
    BMJ Open; 2019 Sep; 9(9):e030950. PubMed ID: 31562155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Deprescribing for older people living in residential aged care facilities: Pharmacist recommendations, doctor acceptance and implementation.
    Quek HW; Etherton-Beer C; Page A; McLachlan AJ; Lo SY; Naganathan V; Kearney L; Hilmer SN; Comans T; Mangin D; Lindley RI; Potter K
    Arch Gerontol Geriatr; 2023 Apr; 107():104910. PubMed ID: 36565605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exploration of GP perspectives on deprescribing antidepressants: a qualitative study.
    Kelly D; Graffi J; Noonan M; Green P; McFarland J; Hayes P; Glynn L
    BMJ Open; 2021 Apr; 11(4):e046054. PubMed ID: 33820792
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzodiazepine Use and Deprescribing in Belgian Nursing Homes: Results from the COME-ON Study.
    Evrard P; Henrard S; Foulon V; Spinewine A
    J Am Geriatr Soc; 2020 Dec; 68(12):2768-2777. PubMed ID: 32786002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attitudes towards deprescribing: The perspectives of geriatric patients and nursing home residents.
    Lundby C; Glans P; Simonsen T; Søndergaard J; Ryg J; Lauridsen HH; Pottegård A
    J Am Geriatr Soc; 2021 Jun; 69(6):1508-1518. PubMed ID: 33598916
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beliefs and attitudes of residents, family members and healthcare professionals regarding deprescribing in long-term care: a qualitative study.
    Rowe S; Pittman N; Balsom C; Druken R; Kelly DV
    Int J Clin Pharm; 2022 Dec; 44(6):1370-1379. PubMed ID: 36201111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Barriers and facilitators to opioid deprescribing among Advanced Nurse Practitioners: A qualitative interview study.
    McCann C; McCauley CO; Harkin D
    J Adv Nurs; 2024 Jun; 80(6):2500-2511. PubMed ID: 38082475
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychotropic medication deprescribing in residential aged care facilities: An exploratory study of the knowledge and attitudes of family members of residents with dementia.
    Lai R; Withiel TD; Angelone M; Redpath C; O'Connor DW; Plakiotis C
    Australas J Ageing; 2022 Dec; 41(4):e356-e363. PubMed ID: 35166431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identifying barriers and facilitators to deprescribing benzodiazepines and sedative hypnotics in the hospital setting using the Theoretical Domains Framework and the Capability, Opportunity, Motivation and Behaviour (COM-B) Model: a qualitative study.
    Keller MS; Carrascoza-Bolanos J; Breda K; Kim LY; Kennelty KA; Leang DW; Murry LT; Nuckols TK; Schnipper JL; Pevnick JM
    BMJ Open; 2023 Feb; 13(2):e066234. PubMed ID: 36813499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Barriers and enablers to monitoring and deprescribing opioid analgesics for chronic non-cancer pain: a systematic review with qualitative evidence synthesis using the Theoretical Domains Framework.
    Cross AJ; Buchbinder R; Mathieson S; Bourne A; Maher CG; Lin CC; O'Connor DA
    BMJ Qual Saf; 2022 May; 31(5):387-400. PubMed ID: 35064054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.